Drug: PAXIL CR Injury: Foetal exposure during pregnancy Quarter: 2016Q3
Total Records: 6 Number of Pages: 1
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 88040123 | PAXIL CR | Foetal exposure during pregnancy | GLAXOSMITHKLINE | 0.00 | F | 0 | 20160720 | US |
| 106937007 | PAXIL CR | Foetal exposure during pregnancy | APOTEX | 0.00 DY | M | 0 | 20160819 | GB |
| 107212659 | PAXIL CR | Foetal exposure during pregnancy | APOTEX | 0.00 YR | F | 3 KG | 20160921 | GB |
| 127870241 | PAXIL CR | Foetal exposure during pregnancy | APOTEX | 0.00 | 0 | 20160928 | GB | |
| 127912472 | PAXIL CR | Foetal exposure during pregnancy | APOTEX | 0.00 DY | F | 3 KG | 20160929 | GB |
| 127916961 | PAXIL CR | Foetal exposure during pregnancy | APOTEX | 0.00 DY | M | 4 KG | 20160929 | GB |
Total Records: 6 Number of Pages: 1